CBS 2019
CBSMD教育中心
中 文

推荐文献

Abstract

Recommended Article

Cardiorespiratory Fitness and Mortality in Healthy Men and Women In-Hospital Costs and Costs of Complications of Chronic Total Occlusion Angioplasty Insights From the OPEN-CTO Registry A sirolimus-eluting bioabsorbable polymer-coated stent (MiStent) versus an everolimus-eluting durable polymer stent (Xience) after percutaneous coronary intervention (DESSOLVE III): a randomised, single-blind, multicentre, non-inferiority, phase 3 trial 2020 AHA/ACC Key Data Elements and Definitions for Coronary Revascularization A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Clinical Data Standards for Coronary Revascularization) Level of Scientific Evidence Underlying the Current American College of Cardiology/American Heart Association Clinical Practice Guidelines Randomized Comparison Between Radial and Femoral Large-Bore Access for Complex Percutaneous Coronary Intervention Impact of Optimal Medical Therapy on 10-Year Mortality After Coronary Revascularization Optimal medical therapy improves clinical outcomes in patients undergoing revascularization with percutaneous coronary intervention or coronary artery bypass grafting: insights from the Synergy Between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) trial at the 5-year follow-up

Original ResearchMarch 17, 2019 [Ahead of Print]

JOURNAL:N Engl J Med. Article Link

Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation

Lopes RD, G Heizer, AUGUSTUS Investigators et al. Keywords: antithrombotic therapy; appropriate antithrombotic regimen; atrial fibrillation; acute coronary syndrome; PCI

FULL TEXT PDF